Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
Titel:
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
Auteur:
Harrison, Claire N Mesa, Ruben Talpaz, Moshe Al-Ali, Haifa Kathrin Xicoy, Blanca Passamonti, Francesco Palandri, Francesca Benevolo, Giulia Vannucchi, Alessandro Maria Mediavilla, Clemence Iurlo, Alessandra Kim, InHo Rose, Shelonitda Brown, Patrick Hernandez, Christopher Wang, Jia Kiladjian, Jean-Jacques